ResearcherIRCCS Humanitas Research HospitalActive in the last 2 years
Alberto Puccini
Matched on ORCID iD 0000-0002-2492-4043; OpenAlex author ID A5033552387. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 44
2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper
Papers 6
- Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients. Co-author DOI 10.1016/j.ejca.2024.114226↗
- Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA… Co-author DOI 10.1007/s00280-023-04585-w↗
- Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets. First author DOI 10.1158/1078-0432.ccr-22-0275↗
- Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients. Co-author DOI 10.3390/cancers14184447↗
- Molecular characteristics of BRCA1/2 and PALB2 mutations in pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/esmoopen-2020-000942↗
- Maintenance Olaparib for Metastatic Pancreatic Cancer. Reply. Co-author DOI 10.1056/nejmc1911185↗
Closest collaborators
The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Stefania Sciallero · 3 shared papers, 2019–2024 · strength 0.43
- Paper Maintenance Olaparib for Metastatic Pancreatic Cancer. Reply. DOI 10.1056/nejmc1911185↗
- Paper Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patien… DOI 10.1016/j.ejca.2024.114226↗
- Paper Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of I… DOI 10.3390/cancers14184447↗
- Marina Macchini · 2 shared papers, 2023–2024 · strength 0.29
- Paper Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patien… DOI 10.1016/j.ejca.2024.114226↗
- Paper Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unkn… DOI 10.1007/s00280-023-04585-w↗
- Giulia Orsi · 2 shared papers, 2023–2024 · strength 0.29
- Paper Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patien… DOI 10.1016/j.ejca.2024.114226↗
- Paper Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unkn… DOI 10.1007/s00280-023-04585-w↗
- Guido Giordano · 2 shared papers, 2023–2024 · strength 0.29
- Paper Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patien… DOI 10.1016/j.ejca.2024.114226↗
- Paper Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unkn… DOI 10.1007/s00280-023-04585-w↗
- Lisa Salvatore · 2 shared papers, 2023–2024 · strength 0.29
- Paper Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patien… DOI 10.1016/j.ejca.2024.114226↗
- Paper Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unkn… DOI 10.1007/s00280-023-04585-w↗
- Giampaolo Tortora · 2 shared papers, 2023–2024 · strength 0.29
- Paper Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patien… DOI 10.1016/j.ejca.2024.114226↗
- Paper Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unkn… DOI 10.1007/s00280-023-04585-w↗
- Michele Reni · 2 shared papers, 2023–2024 · strength 0.29
- Paper Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patien… DOI 10.1016/j.ejca.2024.114226↗
- Paper Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unkn… DOI 10.1007/s00280-023-04585-w↗
- Stefano Cascinu · 2 shared papers, 2023–2024 · strength 0.29
- Paper Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patien… DOI 10.1016/j.ejca.2024.114226↗
- Paper Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unkn… DOI 10.1007/s00280-023-04585-w↗
- William Bruno · 2 shared papers, 2022–2024 · strength 0.27
- Paper Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patien… DOI 10.1016/j.ejca.2024.114226↗
- Paper Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of I… DOI 10.3390/cancers14184447↗
- Bruna Dalmasso · 2 shared papers, 2022–2024 · strength 0.27
- Paper Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patien… DOI 10.1016/j.ejca.2024.114226↗
- Paper Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of I… DOI 10.3390/cancers14184447↗
- Lorenza Pastorino · 2 shared papers, 2022–2024 · strength 0.27
- Paper Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patien… DOI 10.1016/j.ejca.2024.114226↗
- Paper Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of I… DOI 10.3390/cancers14184447↗
- Paola Ghiorzo · 2 shared papers, 2022–2024 · strength 0.27
- Paper Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patien… DOI 10.1016/j.ejca.2024.114226↗
- Paper Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of I… DOI 10.3390/cancers14184447↗
- Andreas Seeber · 2 shared papers, 2020–2022 · strength 0.19
- Florian Kocher · 2 shared papers, 2020–2022 · strength 0.19
- Richard M. Goldberg · 2 shared papers, 2020–2022 · strength 0.19
- Heinz‐Josef Lenz · 2 shared papers, 2020–2022 · strength 0.19
- Michael J. Hall · 2 shared papers, 2020–2022 · strength 0.19
- Wolfgang Michael Korn · 2 shared papers, 2020–2022 · strength 0.19
- John Lindsay Marshall · 2 shared papers, 2020–2022 · strength 0.19
- Anthony Frank Shields · 2 shared papers, 2020–2022 · strength 0.19
- Laura Cortesi · 1 shared paper, 2024 · strength 0.15
- Catia Carconi · 1 shared paper, 2024 · strength 0.15
- Matteo Landriscina · 1 shared paper, 2024 · strength 0.15
- Lívia Archibugi · 1 shared paper, 2024 · strength 0.15
- Marta Chiaravalli · 1 shared paper, 2024 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.